Decreased AKT or increased calpain activity results in the proteolytic degradation of synaptic proteins and mitochondrial damage and eventually neuronal damage and death, which may contribute to cognitive deficits [40,47,52,58,61]. The gene discussed is AKT1; the disease is Cognitive impairment.